MFN2 and Alzheimer disease: Since Mfn2 has been described as a negative regulator of MERCS [5,17,18], in addition to its well-established role in mitochondrial fusion [43], our data suggests that the increased connectivity between ER and mitochondria in these AD models due to the increase in Aβ could be linked with reduced Mfn2 levels.